603155.SS
Xinyaqiang Silicon Chemistry Co.,Ltd [603155.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603155.SS Stock Summary
Top 10 Correlated ETFs
603155.SS
Top 10 Correlated Stocks
603155.SS
In the News
603155.SS Financial details
Company Rating
Strong Buy
Market Cap
3.87B
Income
158.17M
Revenue
729.03M
Book val./share
9.95
Cash/share
7
Dividend
1
Dividend %
4.39%
Employees
454
Optionable
No
Shortable
Yes
Earnings
27 Oct 2023
P/E
31.61
Forward P/E
-
PEG
-6.19
P/S
7.04
P/B
2.23
P/C
2.19
P/FCF
31.68
Quick Ratio
9.3
Current Ratio
10.12
Debt / Equity
0.06
LT Debt / Equity
-
-
-
EPS (TTM)
0.69
EPS next Y
-
EPS next Q
-
EPS this Y
-5.63%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0%
Revenue last 5Y
11.77%
Revenue Q/Q
-13.12%
EPS Q/Q
-59.62%
-
-
-
-
SMA20
-12.75%
SMA50
-19.53%
SMA100
-31.55%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
7%
ROC
0.07%
Gross Margin
26%
Oper. Margin
24%
Profit Margin
22%
Payout
143%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
14.27-30.39
52W High
-48.83%
52W Low
+9.64%
RSI
37.06
Rel Volume
0.54
Avg Volume
816.01K
Volume
444.29K
Perf Week
-12.73%
Perf Month
-15.47%
Perf Quarter
-31.32%
Perf Half Y
-34.46%
-
-
-
-
Beta
0.334
-
-
Volatility
0.98%, 1.18%
Prev Close
-0.32%
Price
15.35
Change
-2.72%
603155.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 4.12 | 2.67 | 2.17 | 3.9 | 5.03 | |
| Net income per share | 1.34 | 0.97 | 0.7 | 1.42 | 1.34 | |
| Operating cash flow per share | 1.13 | 0.94 | 0.68 | 0.84 | 1.33 | |
| Free cash flow per share | 0.98 | 0.75 | 0.4 | 0.46 | 0.31 | |
| Cash per share | 1.47 | 1.3 | 6.93 | 7.13 | 7.27 | |
| Book value per share | 3.26 | 2.95 | 8.72 | 9.76 | 10.4 | |
| Tangible book value per share | 3.12 | 2.85 | 8.63 | 9.67 | 10.09 | |
| Share holders equity per share | 3.26 | 2.95 | 8.72 | 9.76 | 10.4 | |
| Interest debt per share | 0.01 | 0.02 | 0.35 | 0.9 | 0.06 | |
| Market cap | 4.99B | 7.13B | 5.32B | 8.42B | 6.06B | |
| Enterprise value | 4.76B | 6.85B | 5B | 8.38B | 5.62B | |
| P/E ratio | 23.64 | 32.52 | 33.8 | 26.35 | 20.09 | |
| Price to sales ratio | 7.68 | 11.85 | 10.85 | 9.57 | 5.35 | |
| POCF ratio | 27.94 | 33.52 | 34.63 | 44.2 | 20.2 | |
| PFCF ratio | 32.32 | 42.43 | 58.93 | 81.83 | 87.02 | |
| P/B Ratio | 9.71 | 10.73 | 2.7 | 3.83 | 2.58 | |
| PTB ratio | 9.71 | 10.73 | 2.7 | 3.83 | 2.58 | |
| EV to sales | 7.32 | 11.37 | 10.21 | 9.53 | 4.96 | |
| Enterprise value over EBITDA | 17.78 | 24.95 | 25.91 | 21.37 | 16.12 | |
| EV to operating cash flow | 26.64 | 32.17 | 32.58 | 44.02 | 18.73 | |
| EV to free cash flow | 30.82 | 40.72 | 55.44 | 81.5 | 80.68 | |
| Earnings yield | 0.04 | 0.03 | 0.03 | 0.04 | 0.05 | |
| Free cash flow yield | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | |
| Debt to equity | 0 | 0.01 | 0.04 | 0.09 | 0.01 | |
| Debt to assets | 0 | 0.01 | 0.04 | 0.08 | 0 | |
| Net debt to EBITDA | -0.86 | -1.05 | -1.63 | -0.09 | -1.27 | |
| Current ratio | 3.76 | 10.73 | 13.4 | 6.92 | 7.62 | |
| Interest coverage | 267.03 | 1.86K | -347.57 | 0 | 1.48K | |
| Income quality | 0.85 | 0.97 | 0.98 | 0.6 | 0.99 | |
| Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | |
| Payout ratio | 0.16 | 0.28 | 0.36 | 0.27 | 0.52 | |
| Sales general and administrative to revenue | 0.04 | 0.01 | 0.01 | 0 | 0 | |
| Research and developement to revenue | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.03 | 0.03 | 0.01 | 0.01 | 0.04 | |
| Capex to operating cash flow | -0.14 | -0.21 | -0.41 | -0.46 | -0.77 | |
| Capex to revenue | -0.04 | -0.07 | -0.13 | -0.1 | -0.2 | |
| Capex to depreciation | -1.52 | -2.01 | -2.66 | -3.53 | -6.04 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 9.9 | 8.03 | 11.7 | 17.63 | 17.69 | |
| ROIC | 0.41 | 0.33 | 0.07 | 0.13 | 0.13 | |
| Return on tangible assets | 0.35 | 0.32 | 0.08 | 0.13 | 0.12 | |
| Graham Net | 1.45 | 1.57 | 6.95 | 7.02 | 6.97 | |
| Working capital | 314.39M | 426.87M | 1.65B | 1.76B | 1.79B | |
| Tangible asset value | 491.93M | 643.64M | 1.95B | 2.18B | 2.28B | |
| Net current asset value | 308.68M | 421.93M | 1.65B | 1.76B | 1.73B | |
| Invested capital | 0 | 0.01 | 0.04 | 0.09 | 0.01 | |
| Average receivables | 70.68M | 83.98M | 107.35M | 185.03M | 231.61M | |
| Average payables | 61.91M | 64.3M | 73.92M | 193.87M | 236.94M | |
| Average inventory | 88.1M | 101.82M | 91.19M | 143.01M | 190.66M | |
| Days sales outstanding | 44.45 | 53.84 | 93.72 | 101.27 | 70.53 | |
| Days payables outstanding | 105.87 | 34.66 | 150.77 | 195.35 | 95.31 | |
| Days of inventory on hand | 122.59 | 105.84 | 119.41 | 139.4 | 88.08 | |
| Receivables turnover | 8.21 | 6.78 | 3.89 | 3.6 | 5.18 | |
| Payables turnover | 3.45 | 10.53 | 2.42 | 1.87 | 3.83 | |
| Inventory turnover | 2.98 | 3.45 | 3.06 | 2.62 | 4.14 | |
| ROE | 0.41 | 0.33 | 0.08 | 0.15 | 0.13 | |
| Capex per share | -0.15 | -0.2 | -0.28 | -0.39 | -1.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.76 | 0.86 | 1.01 | 0.73 | 0.64 | |
| Net income per share | 0.47 | 0.16 | 0.24 | 0.21 | 0.08 | |
| Operating cash flow per share | 0.47 | 0.16 | 0.24 | 0.33 | 0.23 | |
| Free cash flow per share | -0.25 | 0.08 | 0.19 | 0.3 | 0.15 | |
| Cash per share | 10.19 | 7.27 | 7.5 | 6.97 | 7 | |
| Book value per share | 14.73 | 10.4 | 10.65 | 9.86 | 9.95 | |
| Tangible book value per share | 14.81 | 10.09 | 10.34 | 9.55 | 9.64 | |
| Share holders equity per share | 14.73 | 10.4 | 10.65 | 9.86 | 9.95 | |
| Interest debt per share | 0.27 | 0.06 | 0.06 | 0.66 | 0.56 | |
| Market cap | 3.99B | 6.06B | 6.46B | 5.77B | 5.36B | |
| Enterprise value | 3.56B | 5.62B | 6.02B | 5.54B | 5.08B | |
| P/E ratio | 13.54 | 40.97 | 29.42 | 30.57 | 69.99 | |
| Price to sales ratio | 14.49 | 31.4 | 28.49 | 34.83 | 37.26 | |
| POCF ratio | 54.18 | 163.86 | 117.67 | 76.68 | 101.53 | |
| PFCF ratio | -102.48 | 355.23 | 147.14 | 86.16 | 156.7 | |
| P/B Ratio | 1.73 | 2.58 | 2.69 | 2.59 | 2.39 | |
| PTB ratio | 1.73 | 2.58 | 2.69 | 2.59 | 2.39 | |
| EV to sales | 12.93 | 29.11 | 26.55 | 33.5 | 35.36 | |
| Enterprise value over EBITDA | -457.09 | 59.47 | 105.26 | 90.35 | -3.23K | |
| EV to operating cash flow | 48.35 | 151.91 | 109.65 | 73.73 | 96.37 | |
| EV to free cash flow | -91.46 | 329.32 | 137.11 | 82.85 | 148.73 | |
| Earnings yield | 0.02 | 0.01 | 0.01 | 0.01 | 0 | |
| Free cash flow yield | -0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0.01 | 0.01 | 0.01 | 0.07 | 0.06 | |
| Debt to assets | 0 | 0 | 0 | 0.06 | 0.05 | |
| Net debt to EBITDA | 55.03 | -4.68 | -7.7 | -3.61 | 172.94 | |
| Current ratio | 6.61 | 7.62 | 10.11 | 8.81 | 10.12 | |
| Interest coverage | 2.01 | -78.33 | 645.82 | 158.23 | 350.82 | |
| Income quality | 1 | 1 | 1 | 1.59 | 2.76 | |
| Dividend Yield | 0 | 0 | 0 | 0.04 | 0 | |
| Payout ratio | 0 | 0 | 0 | 4.53 | 0.62 | |
| Sales general and administrative to revenue | 0.05 | -0.06 | 0.03 | -0.02 | 0.09 | |
| Research and developement to revenue | 0.04 | 0.06 | 0.03 | 0.04 | 0.05 | |
| Intangibles to total assets | 0.01 | 0.04 | 0.04 | 0.04 | 0.04 | |
| Capex to operating cash flow | -1.53 | -0.54 | -0.2 | -0.11 | -0.35 | |
| Capex to revenue | -0.41 | -0.1 | -0.05 | -0.05 | -0.13 | |
| Capex to depreciation | -11.5 | -2.04 | -0.94 | -0.71 | 0.8 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 12.48 | 6.2 | 7.64 | 6.81 | 4.36 | |
| ROIC | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Return on tangible assets | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Graham Net | 9.73 | 6.97 | 7.31 | 6.58 | 6.7 | |
| Working capital | 1.75B | 1.79B | 1.87B | 1.7B | 1.72B | |
| Tangible asset value | 2.32B | 2.28B | 2.33B | 2.15B | 2.17B | |
| Net current asset value | 1.7B | 1.73B | 1.79B | 1.62B | 1.63B | |
| Invested capital | 0.01 | 0.01 | 0.01 | 0.07 | 0.06 | |
| Average receivables | 279.52M | 240.59M | 221.36M | 199.48M | 174.46M | |
| Average payables | 288.35M | 241.39M | 172.41M | 155.26M | 165.94M | |
| Average inventory | 189.3M | 193.75M | 174.16M | 162.98M | 159.78M | |
| Days sales outstanding | 85.72 | 102.14 | 88.8 | 95.32 | 108.68 | |
| Days payables outstanding | 125.57 | 134.6 | 80.78 | 121.35 | 118.67 | |
| Days of inventory on hand | 89.52 | 124.38 | 91.8 | 118.76 | 112.28 | |
| Receivables turnover | 1.05 | 0.88 | 1.01 | 0.94 | 0.83 | |
| Payables turnover | 0.72 | 0.67 | 1.11 | 0.74 | 0.76 | |
| Inventory turnover | 1.01 | 0.72 | 0.98 | 0.76 | 0.8 | |
| ROE | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | |
| Capex per share | -0.72 | -0.09 | -0.05 | -0.04 | -0.08 |
603155.SS Frequently Asked Questions
What is Xinyaqiang Silicon Chemistry Co.,Ltd stock symbol ?
Xinyaqiang Silicon Chemistry Co.,Ltd is a CN stock and trading under the symbol 603155.SS
What is Xinyaqiang Silicon Chemistry Co.,Ltd stock quote today ?
Xinyaqiang Silicon Chemistry Co.,Ltd stock price is $15.35 today.
Is Xinyaqiang Silicon Chemistry Co.,Ltd stock public?
Yes, Xinyaqiang Silicon Chemistry Co.,Ltd is a publicly traded company.
Company Profile
- Volume Average 816.01K
- Market Capitalization 3.87B
- Employee 454
- CEO Mr. Yajun Chu
- Headquarters Suqian,CN
- IPO Date 2020-09-01
-
Website
https://www.newasiaman.com 
Xinyaqiang Silicon Chemistry Co.,Ltd manufactures and sells organic silicon methylsilane and phenyl products. It offers hexamethyldisiloxane, iodotrimethylsilane, chlorotrimethylsilane, hexamethyldisilane, diethoxydimethylsilane, dimethoxydimethylsilane, phenyltrichlorosilane, dichlorodiphenylsilane, dichlorodimethylsilane, trimethylethoxysilane, methyltrimethoxysilane, and methyltriethoxysilane; 1,3-divinyltetramethyldisilazane; 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane; N,1,1,1-tetramethyl-N-(trimethylsilyl)silylamine; 1,1,1,3,3,3-hexamethyldisilazane; and 1,3-Bis(trimethylsilyl)urea. The company was founded in 2009 and is based in Suqian, China.
